跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
F-100
首页
药物
F-100
F-100
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Alcoholic pump foam
US 2006182690 A1
申请人: STOCKHAUSEN CHEM FAB GMBH
优先权: 2004
CN
US
8 件公开
Peronospora resistance in Spinacia oleracea
US 11603538 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2018
CN
EP
US
WO
6 件公开
EP 3518659 A1
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2016
EP
US
2 件公开
US 11202421 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2016
US
US 10674688 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2017
US
US 11473102 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2020
US
US 11820993 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2020
US
US 12520787 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2021
US
Immune stimulatory infant nutrition
US 8114441 B2
申请人: BOEHM GUENTHER
优先权: 2004
CN
EP
US
6 件公开
Oil-in-water organopolysiloxane emulsion composition, cosmetic ingredient comprising this composition, and method of producing a hair cosmetic using this composition
US 8546483 B2
申请人: TANAKA HIDEFUMI
优先权: 2008
CN
EP
US
WO
5 件公开
Acid resistant film forming dental composition and method of use
US 6458339 B1
申请人: COX CHARLES F
优先权: 2000
US
5 件公开
ANTI-SETTLING, THICKENING POLYMER AND AQUEOUS CLEANSING FORMULATIONS CONTAINING SAME
EP 3704168 A1
申请人: DOW GLOBAL TECHNOLOGIES LLC
优先权: 2017
CN
EP
US
WO
4 件公开
DEVICE FOR SEPARATING AN ANALYTE FROM OTHER COMPONENTS IN AN ELECTROLYTIC SOLUTION
EP 4419898 A1
申请人: NYCTEA TECH AB
优先权: 2021
CN
EP
US
WO
4 件公开
PRECIPITATED SILICA AND METHODS THEREOF
EP 4615799 A1
申请人: EVONIK OPERATIONS GMBH
优先权: 2022
CN
EP
US
WO
4 件公开
CARBOXY GROUP-MODIFIED ORGANOPOLYSILOXANE HAVING (POLY)GLYCEROL GROUP OR POLYOXYALKYLENE GROUP, AND COSMETIC PREPARATION
US 20260234342 A1
申请人: SHINETSU CHEMICAL CO
优先权: 2023
CN
EP
US
WO
4 件公开
Rhamnose binding protein
US 6930171 B2
申请人: SOLBEC PHARMACEUTICALS LTD
优先权: 2003
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈